General Information
|
|
Product
|
IDO2 Antibody FITC
|
Description
|
FITC-Conjugated Indoleamine 2,3-dioxygenase 2 Antibody
|
Verified Applications
|
ELISA, IHC, IP, WB
|
Host
|
Rabbit
|
Species Cross Reactivity
|
Human, Monkey
|
Immunogen
|
Synthetic peptide taken within amino acid region 370-420 on human Indoleamine 2,3-dioxygenase 2 protein.
|
Physical Properties
|
|
Quantity
|
100 µg
|
Volume
|
200 µl
|
Concentration
|
0.5-1.5 µg/µl in antibody stabilization buffer
|
Immunoglobulin
|
IgG
|
Form
|
FITC-Conjugated
|
Purification Method
|
Immobilized antigen affinity chromatography
|
Clonality
|
Polyclonal
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
ELISA
|
1:50,000
|
Immunohistochemistry |
1:50-1:250 |
Immunoprecipitation
|
1:200
|
Western Blot
|
1:2,500-1:5,000
|
Protein
|
Uniprot #
|
Q6ZQW0
|
Overview
|
Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway (PubMed:17671174). Involved in immune regulation. May not play a significant role in tryptophan-related tumoral resistance.
|
Molecular Function
|
heme binding
indoleamine 2,3-dioxygenase activity
metal ion binding
tryptophan 2,3-dioxygenase activity
|
Subcellular Location
|
cytosol
|
Expression
|
Detected in liver, small intestine, spleen, placenta, thymus, lung, brain, kidney, and colon (PubMed:17671174). Also expressed at low level in testis and thyroid. Not expressed in the majority of human tumor samples (>99%).
|
Structure
|
Belongs to the indoleamine 2,3-dioxygenase family.
|
Alternative Nomenclature
|
3-dioxygenase antibody
I23O1_HUMAN antibody
IDO 2 antibody
IDO antibody
IDO-2 antibody
IDO2 antibody
INDO antibody
indolamine 2,3 dioxygenase antibody
Indole 2 3 dioxygenase antibody
indoleamine 2 3 dioxygenase 1 antibody
indoleamine 2 3 dioxygenase antibody
Indoleamine 2,3-dioxygenase 1 antibody
Indoleamine pyrrole 2 3 dioxygenase antibody
Indoleamine-pyrrole 2 antibody
|
|
|